193 related articles for article (PubMed ID: 1651184)
1. Antenatal suppression of Rh alloimmunization.
Bowman JM
Clin Obstet Gynecol; 1991 Jun; 34(2):296-303. PubMed ID: 1651184
[TBL] [Abstract][Full Text] [Related]
2. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
Baskett TF; Parsons ML; Peddle LJ
CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
[TBL] [Abstract][Full Text] [Related]
3. Controversies in Rh prophylaxis.
Hensleigh PA
Am J Obstet Gynecol; 1985 Sep; 153(1):112-3. PubMed ID: 2994476
[No Abstract] [Full Text] [Related]
4. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures.
Bowman JM; Pollock JM
Transfus Med Rev; 1987 Aug; 1(2):101-12. PubMed ID: 2856541
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
Vŭlcheva B; Spasova K
Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
[No Abstract] [Full Text] [Related]
6. The use of Rh immune globulin: a review.
Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
[No Abstract] [Full Text] [Related]
7. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
Aitken SL; Tichy EM
Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
[TBL] [Abstract][Full Text] [Related]
8. Economics of antenatal prophylaxis.
Cairns JA
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():19-22. PubMed ID: 9863974
[No Abstract] [Full Text] [Related]
9. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
Spasova K; Vŭlcheva B
Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
[No Abstract] [Full Text] [Related]
10. Antenatal prophylaxis of Rh immunization with 250 micrograms anti-D immunoglobulin.
Hermann M; Kjellman H; Ljunggren C
Acta Obstet Gynecol Scand Suppl; 1984; 124():1-15. PubMed ID: 6095582
[TBL] [Abstract][Full Text] [Related]
11. [Adverse effects and patient information].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
[TBL] [Abstract][Full Text] [Related]
12. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.
Mills L; Napier JA
Br J Obstet Gynaecol; 1988 Oct; 95(10):1007-12. PubMed ID: 2847774
[TBL] [Abstract][Full Text] [Related]
13. Reversal of Rh alloimmunization. Fact or fancy?
Bowman JM; Pollock JM
Vox Sang; 1984; 47(3):209-15. PubMed ID: 6087562
[TBL] [Abstract][Full Text] [Related]
14. The prevention of Rh haemolytic disease of the fetus and newborn--general background.
Contreras M
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():7-10. PubMed ID: 9863972
[No Abstract] [Full Text] [Related]
15. The role of Rh antibodies in haemolytic disease of the newborn.
Hadley AG; Kumpel BM
Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
[TBL] [Abstract][Full Text] [Related]
16. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?
Bowman JM
Am J Obstet Gynecol; 1985 Feb; 151(3):289-94. PubMed ID: 2982267
[TBL] [Abstract][Full Text] [Related]
17. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
Lee D
BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
[No Abstract] [Full Text] [Related]
18. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
[No Abstract] [Full Text] [Related]
19. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the Center for Rh-negative Mothers. Hospital Paula Jaraquemada (3 years)].
Krug A; Bianchi R; Pérez N; Ilabaca G; Farías S; Rojas E
Rev Chil Obstet Ginecol; 1981; 46(4):206-14. PubMed ID: 6099901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
